• Nenhum resultado encontrado

Arq Bras Endocrinol Metab vol.50 número3

N/A
N/A
Protected

Academic year: 2018

Share "Arq Bras Endocrinol Metab vol.50 número3"

Copied!
1
0
0

Texto

(1)

HOMA-IR in Brazilians

Ghiringhello et al

574 Arq Bras Endocrinol Metab vol 50 nº 3 Junho 2006

REFERENCES

1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treach-er DF, TurnTreach-er RC. Homeostasis model assessment: insulin resistance and beta-cell function from plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.

2. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.

3. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazil-ian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006;72:219-20.

4. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resis-tance using routine clinical measurements. Diabetes 2005;54:333-9.

5. UKPDS Group: U.K. Prospective Diabetes Study 16: Overview of 6 years’ therapy of type II diabetes: a pro-gressive disease. Diabetes 1995;44:1249-58.

Address for correspondance:

André F. Reis

Av. Gal. Waldomiro de Lima 508 04344-070 São Paulo, SP Fax: (11) 5014-7425

E-mail: andre.reis@fleury.com.br

ERRATUM

Na edição de Abril de 2006, o artigo de Luciana Bahia e colaboradores — “O Endotélio na Síndrome

Metabólica” (Arq Bras Endocrinol Metab 2006; 50/2:291-303), por uma falha na diagramação, foi impresso

com o endereço errado da Instituição.

O endereço correto é:

Referências

Documentos relacionados

Thus for weaker anti-resorptive agents such as raloxifene, whilst the modest reduction in bone turnover is sufficient to reduce fractures at cancellous bone sites where high

The Surgeon General’s “Report on Bone Health and Osteoporosis” (6) and the National Osteoporosis Foundation’s (NOF) “Physician’s Guide to Prevention and Treat- ment

O Brazilian Metabolic Syndrome Study (BRAMS), estudando uma população de apro- ximadamente 2.000 pacientes, com predomínio de obesos e diabéticos tipo 2, demonstrou uma clara

Technologies for the measurement of bone mineral density and other parameters of bone strength at peripheral skeletal sites have been stud- ied since the

Entretanto, a análise imunoquímica dos anticorpos presentes no soro em condições normais demonstrou a presença de auto-anticorpos da classe das imunoglobulinas G (IgG) em

A similar post-hoc analysis of the Fracture Intervention Trial (FIT), examining the influence of pre-treatment bone turnover on the anti-fracture effi- cacy of daily alendronate

CASRdb: Calcium-sensing receptor locus-specific data- base for mutations causing familial (benign) hypocalci- uric hypercalcemia, neonatal severe hyperparathy- roidism, and

In patients attending an osteoporosis clinic, PTH levels clearly increase when the serum levels of 25-hydroxyvitamin D fall to below 25 ng/ml (62.5 nmol/L) and there is a